| Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF) S Rich, D Randall, D Hay US Patent 11,969,424, 2024 | | 2024 |
| A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and … P Ameri, V Mercurio, P Pollesello, MS Anker, J Backs, A Bayes‐Genis, ... European journal of heart failure 26 (4), 707-729, 2024 | 2 | 2024 |
| Toward a Universal Definition of Etiologies in Heart Failure: Categorizing Causes and Advancing Registry Science A Agarwal, J Tromp, W Almahmeed, C Angermann, C Chandramouli, ... Circulation: Heart Failure, e011095, 2024 | 4 | 2024 |
| Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF) S Rich, D Randall, D Hay US Patent 11,701,355, 2023 | 1 | 2023 |
| The transition from chronic intravenous to oral levosimendan is safe and effective in patients with pulmonary hypertension with heart failure and preserved ejection fraction T Thenappan, B Borlaug, D Burkhoff, J Rich, S Shah, R Zolty, S Rich Journal of Cardiac Failure 29 (4), 714-715, 2023 | 3 | 2023 |
| Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF) S Rich, D Randall, D Hay US Patent 11,607,412, 2023 | 2 | 2023 |
| Oral Pulmonary Arterial Hypertension-Targeted Therapy in Patients with Pulmonary Hypertension due to Interstitial Lung Disease KC Selvan, K Teerapuncharoen, M Funk, S Rich, R Bag | | 2023 |
| Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week M Fudim, DM Kaye, BA Borlaug, SJ Shah, S Rich, NK Kapur, ... Journal of the American College of Cardiology 79 (18), 1858-1869, 2022 | 47 | 2022 |
| Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety M Girardis, D Bettex, M Bojan, C Demponeras, S Fruhwald, J Gál, ... Journal of Anesthesia, Analgesia and Critical Care 2 (1), 4, 2022 | 10 | 2022 |
| Prevalence, incidence, and survival of pulmonary arterial hypertension: a systematic review for the global burden of disease 2020 study S Emmons‐Bell, C Johnson, A Boon‐Dooley, PA Corris, PJ Leary, S Rich, ... Pulmonary Circulation 12 (1), e12020, 2022 | 22 | 2022 |
| Levosimendan‐induced venodilation is mediated by opening of potassium channels D Burkhoff, S Rich, P Pollesello, Z Papp ESC heart failure 8 (6), 4454-4464, 2021 | 9 | 2021 |
| Changes in stressed blood volume with levosimendan in pulmonary hypertension from heart failure with preserved ejection fraction: insights regarding mechanism of action from … MI Brener, NB Hamid, K Sunagawa, BA Borlaug, SJ Shah, S Rich, ... Journal of cardiac failure 27 (9), 1023-1026, 2021 | 17 | 2021 |
| Diagnosis and treatment of right heart failure in pulmonary vascular diseases: a national heart, lung, and blood institute workshop JA Leopold, SM Kawut, MA Aldred, SL Archer, RL Benza, MR Bristow, ... Circulation: Heart Failure 14 (6), e007975, 2021 | 17 | 2021 |
| Pharmaceutical compositions for the treatment of pulmonary hypertension AR Hemnes, S Rich US Patent App. 17/101,334, 2021 | | 2021 |
| Levosimendan improves hemodynamics and exercise tolerance in PH-HFpEF: results of the randomized placebo-controlled HELP trial D Burkhoff, BA Borlaug, SJ Shah, R Zolty, RJ Tedford, T Thenappan, ... Heart Failure 9 (5), 360-370, 2021 | 57 | 2021 |
| EXPRESS: Prevalence, Incidence, and Survival of Pulmonary Arterial Hypertension: A Systematic Review for the Global Burden of Disease 2020 Study S Emmons-Bell, C Johnson, A Boon-Dooley, P Corris, PJ Leary, S Rich, ... Pulmonary Circulation, 20458940211061473, 2021 | 1 | 2021 |
| Levosimendan improves hemodynamics and submaximal exercise capacity in PH-HFpEF: primary results from the HELP-PH-HFpEF multicenter randomized controlled trial BA Borlaug, D Burkhoff, S Shah, R Zolty, R Tedford, T Thenappan, ... Journal of Cardiac Failure 26 (12), 1108, 2020 | 5 | 2020 |
| 24-hour Levosimendan Infusion Decreases Biventricular Filling Pressures and Increases Cardiac Output at Rest and Exercise in PH-HFpEF D Burkhoff, BA Borlaug, SJ Shah, S Rich, HELP Study Investigators Circulation 142 (Suppl_3), A15294-A15294, 2020 | 5 | 2020 |
| Cardiac catheterization in pulmonary hypertension: Doing it right, with a catheter on the left G Hansmann, S Rich, BA Maron Cardiovascular Diagnosis and Therapy 10 (5), 1718, 2020 | 7 | 2020 |
| Dual-energy computed tomography as an alternative noninvasive study for evaluation of chronic thromboembolic pulmonary hypertension postoperatively A Desai, SC Malaisrie, M Cuttica, BH Freed, S Rich, D Schimmel, R Avery Circulation: Cardiovascular Imaging 13 (5), e010168, 2020 | 2 | 2020 |
